Share Price and Basic Stock Data
Last Updated: January 20, 2026, 8:32 pm
| PEG Ratio | -3.62 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bharat Rasayan Ltd operates in the agrochemicals sector, focusing on the production of pesticides. The company’s share price stood at ₹2,187, with a market capitalization of ₹3,635 Cr. In terms of revenue, Bharat Rasayan reported total sales of ₹1,234 Cr for the fiscal year ending March 2023, reflecting a decline from ₹1,301 Cr in the previous fiscal year. The trailing twelve months (TTM) sales have shown a slight recovery, reported at ₹1,226 Cr. Quarterly sales figures indicate fluctuations, with the highest sales of ₹310 Cr recorded in March 2024 and a low of ₹239 Cr in June 2023. The sales performance demonstrates the volatility typical of the agrochemicals industry, influenced by seasonal demand and agricultural cycles. The company’s operating profit margin (OPM) for the TTM was recorded at 15%, which is lower than the previous year, indicating potential pressure on pricing and cost management within the sector.
Profitability and Efficiency Metrics
Bharat Rasayan Ltd’s profitability metrics reveal a mixed performance. The net profit for the fiscal year ending March 2023 was reported at ₹125 Cr, a significant drop from ₹176 Cr in March 2022. The company’s net profit margin stood at 10.66% for the year ending March 2025, showing an improvement from 7.81% the previous year. The return on equity (ROE) was reported at 12.4%, while the return on capital employed (ROCE) was 15.5%, demonstrating adequate returns on shareholders’ and capital investments. The interest coverage ratio (ICR) was notably high at 42.60x, indicating that the company comfortably covers its interest obligations, which is a strong sign of financial health. However, the cash conversion cycle (CCC) of 200 days indicates inefficiencies in managing working capital, particularly in inventory and receivables, which could constrain liquidity and operational flexibility.
Balance Sheet Strength and Financial Ratios
The balance sheet of Bharat Rasayan Ltd reflects a robust financial position with total reserves reported at ₹1,193 Cr against borrowings of ₹90 Cr, resulting in a low debt-to-equity ratio of 0.07x. This low leverage indicates a conservative financial strategy, reducing financial risk. The company’s book value per share, including revaluation reserves, was ₹2,719.48, which supports shareholder value. The current ratio stood at 4.19, significantly above the sector average, indicating strong liquidity. However, the price-to-book value ratio (P/BV) at 3.87x suggests that the stock may be trading at a premium compared to its net assets, which could be a concern for value-focused investors. The enterprise value to EBITDA ratio of 21.94x also reflects a high valuation multiple, suggesting that the market has high expectations for future growth, which the company must fulfill to justify its current valuation.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Bharat Rasayan Ltd shows a strong promoter holding of 74.99%, indicating significant management control and alignment with shareholder interests. Foreign Institutional Investors (FIIs) have a minimal stake of 0.47%, while Domestic Institutional Investors (DIIs) hold 2.75%. The public shareholding stands at 21.79%, reflecting a stable investor base. Over the periods reported, the number of shareholders has declined from 17,304 in December 2022 to 15,388 by September 2025, suggesting a consolidation of ownership. This decline could reflect either a lack of retail interest or a strategic reduction in public float. The relatively high promoter stake could instill confidence in long-term investors, while the low FII participation may signal cautious sentiment towards the stock among international investors.
Outlook, Risks, and Final Insight
Looking ahead, Bharat Rasayan Ltd faces both opportunities and challenges. The agrochemicals sector is poised for growth due to rising agricultural productivity demands and increasing crop protection needs. However, the company must navigate risks such as fluctuating raw material prices, regulatory changes, and competition from both domestic and international players. The reported cash conversion cycle of 200 days poses a risk to liquidity, necessitating improved working capital management. Strengths include a solid balance sheet with minimal debt and high interest coverage, which provide a buffer against economic downturns. The company must leverage its strong financial position to invest in innovation and expand its product offerings to enhance market share. Overall, while the current financials indicate stability, the company’s ability to adapt to market dynamics will determine its future performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 4,758 Cr. | 1,102 | 2,114/1,100 | 11.8 | 487 | 0.54 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 791 Cr. | 234 | 391/165 | 16.2 | 131 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 51.1 Cr. | 98.0 | 149/56.6 | 9.15 | 40.0 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 2,748 Cr. | 212 | 331/198 | 104 | 54.9 | 0.07 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 829 Cr. | 23.4 | 37.9/16.3 | 64.7 | 22.8 | 0.85 % | 12.9 % | 9.95 % | 1.00 |
| Industry Average | 10,356.25 Cr | 1,034.70 | 29.24 | 369.04 | 0.47% | 15.21% | 19.87% | 6.67 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 292 | 309 | 306 | 239 | 263 | 233 | 310 | 282 | 328 | 256 | 307 | 377 | 286 |
| Expenses | 256 | 260 | 249 | 234 | 250 | 207 | 240 | 244 | 281 | 215 | 270 | 308 | 253 |
| Operating Profit | 36 | 49 | 56 | 6 | 13 | 26 | 69 | 38 | 47 | 42 | 37 | 69 | 33 |
| OPM % | 12% | 16% | 18% | 2% | 5% | 11% | 22% | 14% | 14% | 16% | 12% | 18% | 12% |
| Other Income | 3 | 6 | -3 | 9 | 4 | 4 | 22 | 22 | 7 | 18 | 6 | -8 | 11 |
| Interest | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 7 | 7 | 6 | 6 | 6 | 7 | 6 | 6 | 6 | 7 | 7 | 6 | 6 |
| Profit before tax | 31 | 46 | 46 | 8 | 10 | 22 | 84 | 53 | 46 | 52 | 35 | 54 | 36 |
| Tax % | 26% | 27% | 34% | 8% | 39% | 29% | 20% | 19% | 30% | 21% | 27% | 26% | 23% |
| Net Profit | 23 | 34 | 30 | 7 | 6 | 15 | 67 | 43 | 32 | 41 | 25 | 40 | 28 |
| EPS in Rs | 13.81 | 20.34 | 18.22 | 4.27 | 3.61 | 9.22 | 40.43 | 25.98 | 19.36 | 24.42 | 15.14 | 23.89 | 16.80 |
Last Updated: January 2, 2026, 6:03 am
Below is a detailed analysis of the quarterly data for Bharat Rasayan Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 286.00 Cr.. The value appears to be declining and may need further review. It has decreased from 377.00 Cr. (Jun 2025) to 286.00 Cr., marking a decrease of 91.00 Cr..
- For Expenses, as of Sep 2025, the value is 253.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 308.00 Cr. (Jun 2025) to 253.00 Cr., marking a decrease of 55.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 33.00 Cr.. The value appears to be declining and may need further review. It has decreased from 69.00 Cr. (Jun 2025) to 33.00 Cr., marking a decrease of 36.00 Cr..
- For OPM %, as of Sep 2025, the value is 12.00%. The value appears to be declining and may need further review. It has decreased from 18.00% (Jun 2025) to 12.00%, marking a decrease of 6.00%.
- For Other Income, as of Sep 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from -8.00 Cr. (Jun 2025) to 11.00 Cr., marking an increase of 19.00 Cr..
- For Interest, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 6.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 36.00 Cr.. The value appears to be declining and may need further review. It has decreased from 54.00 Cr. (Jun 2025) to 36.00 Cr., marking a decrease of 18.00 Cr..
- For Tax %, as of Sep 2025, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Jun 2025) to 23.00%, marking a decrease of 3.00%.
- For Net Profit, as of Sep 2025, the value is 28.00 Cr.. The value appears to be declining and may need further review. It has decreased from 40.00 Cr. (Jun 2025) to 28.00 Cr., marking a decrease of 12.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 16.80. The value appears to be declining and may need further review. It has decreased from 23.89 (Jun 2025) to 16.80, marking a decrease of 7.09.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:33 am
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 989 | 1,213 | 1,091 | 1,301 | 1,234 | 1,044 | 1,171 | 1,226 |
| Expenses | 802 | 983 | 852 | 1,050 | 1,043 | 926 | 996 | 1,045 |
| Operating Profit | 188 | 230 | 240 | 250 | 191 | 118 | 175 | 181 |
| OPM % | 19% | 19% | 22% | 19% | 15% | 11% | 15% | 15% |
| Other Income | 1 | 14 | 6 | 16 | 15 | 35 | 42 | 27 |
| Interest | 16 | 16 | 4 | 7 | 6 | 3 | 5 | 5 |
| Depreciation | 17 | 22 | 26 | 25 | 26 | 26 | 27 | 27 |
| Profit before tax | 155 | 205 | 215 | 234 | 174 | 123 | 185 | 176 |
| Tax % | 28% | 23% | 24% | 25% | 28% | 23% | 24% | |
| Net Profit | 112 | 158 | 164 | 176 | 125 | 96 | 141 | 133 |
| EPS in Rs | 65.60 | 92.73 | 96.39 | 106.01 | 75.07 | 57.54 | 84.89 | 80.25 |
| Dividend Payout % | 1% | 0% | 0% | 0% | 0% | 1% | 0% |
YoY Net Profit Growth
| Year | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 41.07% | 3.80% | 7.32% | -28.98% | -23.20% | 46.88% |
| Change in YoY Net Profit Growth (%) | 0.00% | -37.27% | 3.52% | -36.29% | 5.78% | 70.08% |
Bharat Rasayan Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2019-2020 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -1% |
| 3 Years: | -3% |
| TTM: | 17% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -4% |
| 3 Years: | -9% |
| TTM: | 12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 2% |
| 3 Years: | -7% |
| 1 Year: | -20% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 16% |
| 3 Years: | 12% |
| Last Year: | 12% |
Last Updated: September 5, 2025, 12:55 am
Balance Sheet
Last Updated: December 4, 2025, 1:03 am
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves | 405 | 560 | 723 | 766 | 889 | 984 | 1,126 | 1,193 |
| Borrowings | 247 | 94 | 58 | 174 | 28 | 80 | 85 | 90 |
| Other Liabilities | 100 | 94 | 122 | 142 | 152 | 129 | 193 | 168 |
| Total Liabilities | 756 | 752 | 908 | 1,086 | 1,074 | 1,197 | 1,408 | 1,456 |
| Fixed Assets | 150 | 203 | 191 | 228 | 225 | 230 | 230 | 223 |
| CWIP | 35 | 18 | 18 | 11 | 11 | 6 | 15 | 25 |
| Investments | 0 | 9 | 150 | 43 | 67 | 143 | 298 | 298 |
| Other Assets | 570 | 522 | 549 | 803 | 771 | 818 | 865 | 910 |
| Total Assets | 756 | 752 | 908 | 1,086 | 1,074 | 1,197 | 1,408 | 1,456 |
Below is a detailed analysis of the balance sheet data for Bharat Rasayan Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,193.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,126.00 Cr. (Mar 2025) to 1,193.00 Cr., marking an increase of 67.00 Cr..
- For Borrowings, as of Sep 2025, the value is 90.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 85.00 Cr. (Mar 2025) to 90.00 Cr., marking an increase of 5.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 168.00 Cr.. The value appears to be improving (decreasing). It has decreased from 193.00 Cr. (Mar 2025) to 168.00 Cr., marking a decrease of 25.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,456.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,408.00 Cr. (Mar 2025) to 1,456.00 Cr., marking an increase of 48.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 223.00 Cr.. The value appears to be declining and may need further review. It has decreased from 230.00 Cr. (Mar 2025) to 223.00 Cr., marking a decrease of 7.00 Cr..
- For CWIP, as of Sep 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2025) to 25.00 Cr., marking an increase of 10.00 Cr..
- For Investments, as of Sep 2025, the value is 298.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 298.00 Cr..
- For Other Assets, as of Sep 2025, the value is 910.00 Cr.. The value appears strong and on an upward trend. It has increased from 865.00 Cr. (Mar 2025) to 910.00 Cr., marking an increase of 45.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,456.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,408.00 Cr. (Mar 2025) to 1,456.00 Cr., marking an increase of 48.00 Cr..
Notably, the Reserves (1,193.00 Cr.) exceed the Borrowings (90.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | -59.00 | 136.00 | 182.00 | 76.00 | 163.00 | 38.00 | 90.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 103 | 75 | 99 | 130 | 96 | 138 | 131 |
| Inventory Days | 112 | 70 | 90 | 120 | 141 | 135 | 136 |
| Days Payable | 24 | 17 | 33 | 30 | 33 | 37 | 67 |
| Cash Conversion Cycle | 191 | 128 | 156 | 221 | 204 | 236 | 200 |
| Working Capital Days | 96 | 94 | 114 | 136 | 165 | 199 | 170 |
| ROCE % | 34% | 31% | 28% | 20% | 12% | 16% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| PGIM India Midcap Fund | 63,964 | 0.58 | 66.54 | N/A | N/A | N/A |
| PGIM India Small Cap Fund | 25,978 | 1.69 | 27.02 | 26,931 | 2025-12-08 02:13:57 | -3.54% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 339.14 | 229.86 | 299.89 | 423.52 | 385.70 |
| Diluted EPS (Rs.) | 339.14 | 229.86 | 299.89 | 423.52 | 385.70 |
| Cash EPS (Rs.) | 366.03 | 258.47 | 377.50 | 486.31 | 447.73 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 2719.48 | 2377.47 | 2149.86 | 1853.14 | 1711.78 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 2719.48 | 2377.47 | 2149.86 | 1853.14 | 1711.78 |
| Revenue From Operations / Share (Rs.) | 2822.98 | 2514.02 | 2970.60 | 3131.39 | 2570.20 |
| PBDIT / Share (Rs.) | 483.48 | 332.50 | 521.37 | 651.03 | 580.53 |
| PBIT / Share (Rs.) | 418.53 | 270.43 | 458.73 | 591.01 | 519.90 |
| PBT / Share (Rs.) | 407.18 | 263.32 | 433.75 | 565.14 | 508.26 |
| Net Profit / Share (Rs.) | 301.08 | 196.40 | 314.86 | 426.29 | 387.10 |
| NP After MI And SOA / Share (Rs.) | 339.15 | 229.86 | 299.89 | 423.53 | 385.70 |
| PBDIT Margin (%) | 17.12 | 13.22 | 17.55 | 20.79 | 22.58 |
| PBIT Margin (%) | 14.82 | 10.75 | 15.44 | 18.87 | 20.22 |
| PBT Margin (%) | 14.42 | 10.47 | 14.60 | 18.04 | 19.77 |
| Net Profit Margin (%) | 10.66 | 7.81 | 10.59 | 13.61 | 15.06 |
| NP After MI And SOA Margin (%) | 12.01 | 9.14 | 10.09 | 13.52 | 15.00 |
| Return on Networth / Equity (%) | 12.47 | 9.66 | 13.94 | 22.85 | 22.53 |
| Return on Capital Employeed (%) | 15.15 | 11.23 | 21.10 | 31.43 | 29.94 |
| Return On Assets (%) | 10.00 | 7.97 | 11.60 | 16.14 | 18.04 |
| Total Debt / Equity (X) | 0.07 | 0.08 | 0.03 | 0.22 | 0.08 |
| Asset Turnover Ratio (%) | 0.90 | 0.91 | 1.14 | 1.30 | 1.32 |
| Current Ratio (X) | 4.19 | 4.60 | 4.64 | 2.59 | 3.82 |
| Quick Ratio (X) | 3.08 | 3.25 | 2.74 | 1.70 | 2.83 |
| Inventory Turnover Ratio (X) | 4.21 | 2.30 | 2.85 | 4.16 | 4.04 |
| Dividend Payout Ratio (NP) (%) | 0.44 | 0.65 | 0.50 | 0.00 | 0.38 |
| Dividend Payout Ratio (CP) (%) | 0.37 | 0.51 | 0.41 | 0.00 | 0.33 |
| Earning Retention Ratio (%) | 99.56 | 99.35 | 99.50 | 0.00 | 99.62 |
| Cash Earning Retention Ratio (%) | 99.63 | 99.49 | 99.59 | 0.00 | 99.67 |
| Interest Coverage Ratio (X) | 42.60 | 46.73 | 37.31 | 39.68 | 67.02 |
| Interest Coverage Ratio (Post Tax) (X) | 27.53 | 28.60 | 24.32 | 27.56 | 46.03 |
| Enterprise Value (Cr.) | 4407.24 | 3562.69 | 3772.42 | 5228.04 | 4021.85 |
| EV / Net Operating Revenue (X) | 3.76 | 3.41 | 3.06 | 4.02 | 3.68 |
| EV / EBITDA (X) | 21.94 | 25.79 | 17.41 | 19.33 | 16.31 |
| MarketCap / Net Operating Revenue (X) | 3.73 | 3.38 | 3.06 | 3.89 | 3.66 |
| Retention Ratios (%) | 99.55 | 99.34 | 99.49 | 0.00 | 99.61 |
| Price / BV (X) | 3.87 | 3.57 | 4.23 | 6.57 | 5.49 |
| Price / Net Operating Revenue (X) | 3.73 | 3.38 | 3.06 | 3.89 | 3.66 |
| EarningsYield | 0.03 | 0.02 | 0.03 | 0.03 | 0.04 |
After reviewing the key financial ratios for Bharat Rasayan Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 339.14. This value is within the healthy range. It has increased from 229.86 (Mar 24) to 339.14, marking an increase of 109.28.
- For Diluted EPS (Rs.), as of Mar 25, the value is 339.14. This value is within the healthy range. It has increased from 229.86 (Mar 24) to 339.14, marking an increase of 109.28.
- For Cash EPS (Rs.), as of Mar 25, the value is 366.03. This value is within the healthy range. It has increased from 258.47 (Mar 24) to 366.03, marking an increase of 107.56.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2,719.48. It has increased from 2,377.47 (Mar 24) to 2,719.48, marking an increase of 342.01.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2,719.48. It has increased from 2,377.47 (Mar 24) to 2,719.48, marking an increase of 342.01.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,822.98. It has increased from 2,514.02 (Mar 24) to 2,822.98, marking an increase of 308.96.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 483.48. This value is within the healthy range. It has increased from 332.50 (Mar 24) to 483.48, marking an increase of 150.98.
- For PBIT / Share (Rs.), as of Mar 25, the value is 418.53. This value is within the healthy range. It has increased from 270.43 (Mar 24) to 418.53, marking an increase of 148.10.
- For PBT / Share (Rs.), as of Mar 25, the value is 407.18. This value is within the healthy range. It has increased from 263.32 (Mar 24) to 407.18, marking an increase of 143.86.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 301.08. This value is within the healthy range. It has increased from 196.40 (Mar 24) to 301.08, marking an increase of 104.68.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 339.15. This value is within the healthy range. It has increased from 229.86 (Mar 24) to 339.15, marking an increase of 109.29.
- For PBDIT Margin (%), as of Mar 25, the value is 17.12. This value is within the healthy range. It has increased from 13.22 (Mar 24) to 17.12, marking an increase of 3.90.
- For PBIT Margin (%), as of Mar 25, the value is 14.82. This value is within the healthy range. It has increased from 10.75 (Mar 24) to 14.82, marking an increase of 4.07.
- For PBT Margin (%), as of Mar 25, the value is 14.42. This value is within the healthy range. It has increased from 10.47 (Mar 24) to 14.42, marking an increase of 3.95.
- For Net Profit Margin (%), as of Mar 25, the value is 10.66. This value exceeds the healthy maximum of 10. It has increased from 7.81 (Mar 24) to 10.66, marking an increase of 2.85.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.01. This value is within the healthy range. It has increased from 9.14 (Mar 24) to 12.01, marking an increase of 2.87.
- For Return on Networth / Equity (%), as of Mar 25, the value is 12.47. This value is below the healthy minimum of 15. It has increased from 9.66 (Mar 24) to 12.47, marking an increase of 2.81.
- For Return on Capital Employeed (%), as of Mar 25, the value is 15.15. This value is within the healthy range. It has increased from 11.23 (Mar 24) to 15.15, marking an increase of 3.92.
- For Return On Assets (%), as of Mar 25, the value is 10.00. This value is within the healthy range. It has increased from 7.97 (Mar 24) to 10.00, marking an increase of 2.03.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.07. This value is within the healthy range. It has decreased from 0.08 (Mar 24) to 0.07, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.90. It has decreased from 0.91 (Mar 24) to 0.90, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 4.19. This value exceeds the healthy maximum of 3. It has decreased from 4.60 (Mar 24) to 4.19, marking a decrease of 0.41.
- For Quick Ratio (X), as of Mar 25, the value is 3.08. This value exceeds the healthy maximum of 2. It has decreased from 3.25 (Mar 24) to 3.08, marking a decrease of 0.17.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.21. This value is within the healthy range. It has increased from 2.30 (Mar 24) to 4.21, marking an increase of 1.91.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 20. It has decreased from 0.65 (Mar 24) to 0.44, marking a decrease of 0.21.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 20. It has decreased from 0.51 (Mar 24) to 0.37, marking a decrease of 0.14.
- For Earning Retention Ratio (%), as of Mar 25, the value is 99.56. This value exceeds the healthy maximum of 70. It has increased from 99.35 (Mar 24) to 99.56, marking an increase of 0.21.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 99.63. This value exceeds the healthy maximum of 70. It has increased from 99.49 (Mar 24) to 99.63, marking an increase of 0.14.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 42.60. This value is within the healthy range. It has decreased from 46.73 (Mar 24) to 42.60, marking a decrease of 4.13.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 27.53. This value is within the healthy range. It has decreased from 28.60 (Mar 24) to 27.53, marking a decrease of 1.07.
- For Enterprise Value (Cr.), as of Mar 25, the value is 4,407.24. It has increased from 3,562.69 (Mar 24) to 4,407.24, marking an increase of 844.55.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.76. This value exceeds the healthy maximum of 3. It has increased from 3.41 (Mar 24) to 3.76, marking an increase of 0.35.
- For EV / EBITDA (X), as of Mar 25, the value is 21.94. This value exceeds the healthy maximum of 15. It has decreased from 25.79 (Mar 24) to 21.94, marking a decrease of 3.85.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.73. This value exceeds the healthy maximum of 3. It has increased from 3.38 (Mar 24) to 3.73, marking an increase of 0.35.
- For Retention Ratios (%), as of Mar 25, the value is 99.55. This value exceeds the healthy maximum of 70. It has increased from 99.34 (Mar 24) to 99.55, marking an increase of 0.21.
- For Price / BV (X), as of Mar 25, the value is 3.87. This value exceeds the healthy maximum of 3. It has increased from 3.57 (Mar 24) to 3.87, marking an increase of 0.30.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.73. This value exceeds the healthy maximum of 3. It has increased from 3.38 (Mar 24) to 3.73, marking an increase of 0.35.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bharat Rasayan Ltd:
- Net Profit Margin: 10.66%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.15% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 12.47% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 27.53
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.08
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 19.6 (Industry average Stock P/E: 29.24)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.07
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.66%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | 1501, Vikram Tower, New Delhi Delhi 110008 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sat Narain Gupta | Chairman & Managing Director |
| Mr. Mahabir Prasad Gupta | Whole Time Director |
| Mr. Rajender Prasad Gupta | WholeTime Director & CEO |
| Mr. Ajay Gupta | Executive Director |
| Mr. Kamleshwar Prasad Uniyal | Executive Director |
| Mr. Suresh Kumar Garg | Ind. Non-Executive Director |
| Mr. Ankit Aggarwal | Ind. Non-Executive Director |
| Ms. Mukta Gupta | Ind. Non-Executive Director |
| Mr. Rajesh Gupta | Ind. Non-Executive Director |
| Mr. Naman Jain | Ind. Non-Executive Director |
| Mr. Upendra Singh | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Bharat Rasayan Ltd?
Bharat Rasayan Ltd's intrinsic value (as of 21 January 2026) is ₹1326.21 which is 21.53% lower the current market price of ₹1,690.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,808 Cr. market cap, FY2025-2026 high/low of ₹3,030/1,652, reserves of ₹1,193 Cr, and liabilities of ₹1,456 Cr.
What is the Market Cap of Bharat Rasayan Ltd?
The Market Cap of Bharat Rasayan Ltd is 2,808 Cr..
What is the current Stock Price of Bharat Rasayan Ltd as on 21 January 2026?
The current stock price of Bharat Rasayan Ltd as on 21 January 2026 is ₹1,690.
What is the High / Low of Bharat Rasayan Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bharat Rasayan Ltd stocks is ₹3,030/1,652.
What is the Stock P/E of Bharat Rasayan Ltd?
The Stock P/E of Bharat Rasayan Ltd is 19.6.
What is the Book Value of Bharat Rasayan Ltd?
The Book Value of Bharat Rasayan Ltd is 721.
What is the Dividend Yield of Bharat Rasayan Ltd?
The Dividend Yield of Bharat Rasayan Ltd is 0.02 %.
What is the ROCE of Bharat Rasayan Ltd?
The ROCE of Bharat Rasayan Ltd is 15.5 %.
What is the ROE of Bharat Rasayan Ltd?
The ROE of Bharat Rasayan Ltd is 12.4 %.
What is the Face Value of Bharat Rasayan Ltd?
The Face Value of Bharat Rasayan Ltd is 5.00.